{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:25:33Z","timestamp":1767875133235,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","award":["NCRADA-NMR-09-3183"],"award-info":[{"award-number":["NCRADA-NMR-09-3183"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","award":["WUN A1009"],"award-info":[{"award-number":["WUN A1009"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","award":["NCRADA-NMR-09-3183"],"award-info":[{"award-number":["NCRADA-NMR-09-3183"]}],"id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","award":["WUN A1009"],"award-info":[{"award-number":["WUN A1009"]}],"id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009896","name":"U.S. Navy","doi-asserted-by":"publisher","award":["NCRADA-NMR-09-3183"],"award-info":[{"award-number":["NCRADA-NMR-09-3183"]}],"id":[{"id":"10.13039\/100009896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009896","name":"U.S. Navy","doi-asserted-by":"publisher","award":["WUN A1009"],"award-info":[{"award-number":["WUN A1009"]}],"id":[{"id":"10.13039\/100009896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.034","type":"journal-article","created":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T22:18:14Z","timestamp":1608502694000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6\u00a0+\u00a0ETEC challenge model"],"prefix":"10.1016","volume":"39","author":[{"given":"A.","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.D.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-9458","authenticated-orcid":false,"suffix":"Jr.","given":"M.","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Royal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Rollenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Heinrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Prouty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-9709","authenticated-orcid":false,"given":"M.P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Renauld-Mong\u00e9nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.12.034_b0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990\u20132016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.12.034_b0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14760584.7.6.795","article-title":"Vaccines against enterotoxigenic Escherichia coli","volume":"7","author":"Svennerholm","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.12.034_b0015","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1572-0241.2006.00654.x","article-title":"Postinfectious irritable bowel syndrome\u2013a meta-analysis","volume":"101","author":"Halvorson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2020.12.034_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/jtm.12114","article-title":"Persistent abdominal symptoms in US adults after short-term stay in Mexico","volume":"21","author":"Nair","year":"2014","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.12.034_b0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.12.034_b0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2310\/7060.2002.23206","article-title":"Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico","volume":"9","author":"Bouckenooghe","year":"2002","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.12.034_b0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.diagmicrobio.2009.10.002","article-title":"The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli","volume":"66","author":"Porter","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.12.034_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JCM.38.1.27-31.2000","article-title":"Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh","volume":"38","author":"Qadri","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.12.034_b0045","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0264-410X(02)00613-8","article-title":"Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen","volume":"21","author":"Katz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0055","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0060","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1016\/j.vaccine.2011.09.096","article-title":"Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice","volume":"29","author":"Tobias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/IAI.01131-06","article-title":"Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli","volume":"75","author":"Coster","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.12.034_b0070","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1016\/j.vaccine.2011.05.021","article-title":"A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)","volume":"29","author":"Porter","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0075","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/IAI.70.4.1874-1880.2002","article-title":"Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously","volume":"70","author":"Guerena-Burgueno","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.12.034_b0080","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/CVI.00491-07","article-title":"Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G","volume":"15","author":"Lapa","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.12.034_b0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.12.034_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00788-18","article-title":"Biochemical and Immunological Evaluation of Recombinant CS6-Derived Subunit Enterotoxigenic Escherichia coli Vaccine Candidates","volume":"87","author":"Poole","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.12.034_b0095","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00634-18","article-title":"Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic Escherichia coli Disease for Vaccine Development","volume":"87","author":"Rollenhagen","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.12.034_b0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.vaccine.2015.11.017","article-title":"Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates","volume":"34","author":"Sincock","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(99)00168-1","article-title":"The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)","volume":"18","author":"Cheng","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.034_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-019-0116-6","article-title":"The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine","volume":"4","author":"Liang","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2020.12.034_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/461941","article-title":"Applications of flow cytometry to characterize bacterial physiological responses","volume":"2014","author":"Ambriz-Avina","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2020.12.034_b0120","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/nprot.2016.091","article-title":"Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry","volume":"11","author":"Moor","year":"2016","journal-title":"Nat Protoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:48Z","timestamp":1759402308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20316017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20316017"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6\u00a0+\u00a0ETEC challenge model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}